ve started with Hepsera, there
is no need to change. He felt that the resisitance rate
for Hepsera (vs.
Viread and Baraclude)
is overstated; many patients develop no resistance at all, and the resistance rate, while higher than those for Viread/Baraclude, is not that much higher. Plus, if you do develop resistance, that's when you should start taking Viread (as mono or combo, he didn't say). And Viread is very effective in stopping Hepsera resistance.